Literature DB >> 18752821

HIV-2 induces NF-kappaB activation and cyclooxygenase-2 expression in human astroglial cells.

Susana Alvarez1, Almudena Blanco, Florian Kern, Manuel Fresno, Ma Angeles Muñoz-Fernández.   

Abstract

HIV-2 invades CNS and causes neurological disease as well as HIV-1 does. Induction of COX-2 in CNS of HIV-1 infected people has been proposed as a cause of cognitive impairment, so we tested whether HIV-2 may cause damage by a similar mechanism. COX-2 mRNA and protein expression were induced in human astrocytes upon interaction with HIV-2, being this induction abrogated by CXCR4 antagonists. HIV-2 induced COX-2 promoter transcription and deletion of the two NF-kappaB binding sites of the promoter abrogated this induction. Neither AP-1 nor NFAT seem to be involved in COX-2 transcriptional activation. Overexpression of IkappaBalpha completely abrogated COX-2 induction, and transfection of p65/relA NF-kappaB induced COX-2 transcription. Interestingly, HIV-2 activated NF-kappaB by inducing p65/relA transactivating activity through Ser536 phosphorylation. Moreover, the astrocyte activation induced by HIV-2 was abrogated by different COX inhibitors. In summary, HIV-2 induces COX-2 in human astrocytes depending on CXCR4 coreceptor.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18752821     DOI: 10.1016/j.virol.2008.07.008

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  4 in total

1.  Cyclooxygenase-2 inhibitor blocks the production of West Nile virus-induced neuroinflammatory markers in astrocytes.

Authors:  Saguna Verma; Mukesh Kumar; Vivek R Nerurkar
Journal:  J Gen Virol       Date:  2010-11-24       Impact factor: 3.891

2.  Bryostatin activates HIV-1 latent expression in human astrocytes through a PKC and NF-ĸB-dependent mechanism.

Authors:  Laura Díaz; Marta Martínez-Bonet; Javier Sánchez; Alejandra Fernández-Pineda; José Luis Jiménez; Eduardo Muñoz; Santiago Moreno; Susana Álvarez; Ma Ángeles Muñoz-Fernández
Journal:  Sci Rep       Date:  2015-07-22       Impact factor: 4.379

3.  Synergistic effects of amyloid peptides and lead on human neuroblastoma cells.

Authors:  Challa Suresh; Johnny Johnson; Roshini Mohan; Chellu S Chetty
Journal:  Cell Mol Biol Lett       Date:  2012-05-18       Impact factor: 5.787

4.  Ramatroban as a Novel Immunotherapy for COVID-19.

Authors:  Ajay Gupta; Kamyar Kalantar-Zadeh; Srinivasa T Reddy
Journal:  J Mol Genet Med       Date:  2020-07-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.